A Committed Team
Our Leadership
We are dedicated to applying our greater understanding of the NLRP3 inflammasome and its role in driving disease to develop industry leading inhibitors. Helping patients is our primary motivation and we are fortunate to be in a position to use our combined expertise and many years of industry experience to develop ground-breaking medicines to combat many debilitating diseases.
Management
Board of Directors
Scientific Advisory Board
Senior Advisors
Our Investors
We are proud to be working with a number of partners and investors who share and respect our vision.
Follow our Progress & Insights
Inflazome is making rapid progress in advancing our clinical and preclinical assets. Keep up with the latest news on Inflazome’s research and development activities with regular email updates.